- Home
- KURA vs BY Comparison
KURA vs BY Comparison
Compare KURA & BY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KURA
- BY
- Stock Information
- Founded
- KURA 2014
- BY 1914
- Country
- KURA United States
- BY United States
- Employees
- KURA N/A
- BY N/A
- Industry
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- BY Major Banks
- Sector
- KURA Health Care
- BY Finance
- Exchange
- KURA Nasdaq
- BY Nasdaq
- Market Cap
- KURA 793.2M
- BY 1.2B
- IPO Year
- KURA N/A
- BY 2017
- Fundamental
- Price
- KURA $7.26
- BY $27.69
- Analyst Decision
- KURA Strong Buy
- BY Hold
- Analyst Count
- KURA 11
- BY 3
- Target Price
- KURA $27.89
- BY $32.00
- AVG Volume (30 Days)
- KURA 1.8M
- BY 116.6K
- Earning Date
- KURA 02-25-2025
- BY 01-23-2025
- Dividend Yield
- KURA N/A
- BY 1.30%
- EPS Growth
- KURA N/A
- BY 6.38
- EPS
- KURA N/A
- BY 2.76
- Revenue
- KURA N/A
- BY $373,634,000.00
- Revenue This Year
- KURA N/A
- BY N/A
- Revenue Next Year
- KURA $233.30
- BY $3.24
- P/E Ratio
- KURA N/A
- BY $10.06
- Revenue Growth
- KURA N/A
- BY 9.77
- 52 Week Low
- KURA $6.98
- BY $19.70
- 52 Week High
- KURA $24.17
- BY $32.89
- Technical
- Relative Strength Index (RSI)
- KURA 17.38
- BY 36.57
- Support Level
- KURA $6.98
- BY $26.55
- Resistance Level
- KURA $8.88
- BY $28.80
- Average True Range (ATR)
- KURA 0.33
- BY 0.62
- MACD
- KURA 0.05
- BY -0.17
- Stochastic Oscillator
- KURA 13.40
- BY 39.72
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operation of the group is carried through the United States.
About BY Byline Bancorp Inc.
Byline Bancorp Inc is the holding company for Byline Bank, a full-service commercial bank serving small-and-medium-sized businesses, financial sponsors, and consumers. The company offers a broad range of banking products and services to small and medium sized businesses, commercial real estate and online account opening to consumer and business. Also provide trust and wealth management services to our customers. In addition to traditional commercial banking business, company provide small ticket equipment leasing solutions through Byline Financial Group, a wholly-owned subsidiary of Byline Bank.